Chongqing Adrenogenic Autonomic Cortisol Secretion Cohort Study
- Diagnosis
- Treatment
- Adrenogenic Autonomic Cortisol Secretion
At a glance
- Phase
- Phase not stated
- Study type
- Observational
- Sponsor
- Chongqing Medical University
- Enrolment target
- 200
- Started
- 17 February 2023
- Main results due
- 15 February 2033
- Study sites
- 1
- Registry updated
- 24 September 2026
Can you take part?
- No age limit is stated.
- Open to any sex.
- You need the condition being studied — healthy volunteers are not accepted.
These are the headline rules only. Every study has a longer list, and whether you are eligible is decided by the research team at the site — never by this page.
Read the full eligibility criteria
Inclusion Criteria: * CT examination revealed adrenal nodules (maximum diameter ≥10mm); * Serum cortisol \> 50nmol/L after 1mg dexamethasone inhibition test (1mg-DST). Exclusion Criteria: * Patients with primary aldosteronism (PA), pheochromocytoma, adrenal metastatic carcinoma, congenital adrenal hyperplasia (CAH), ganglionic neuroma/paraganglioma, schwannoma, adrenal hematoma and those with no definite diagnosis were evaluated by clinical and endocrine function. * Patients with serious underlying diseases (such as liver and kidney failure, acute severe infection, etc.) that may affect the function of the hypothalamic-pituitary-adrenal axis (HPA axis); Pregnancy. * Patients with a history of alcoholism, fatigue, trauma, infection, depression, glucocorticoid use, and other drugs affecting the function of the hypothalamic-pituitary-adrenal axis. * Patients who are not willing to participate in and complete this study refuse to sign the written informed consent for this study.
What this study is about
In the sponsor’s own words, from the registry.
To investige the etiology, pathogenesis, diagnosis and treatment of adrenogenic autonomic cortisol secretion in Chinese adults.
Study sites(1)
Department of Endocrinology, Sichuan-Chongqing Joint Key Laboratory of Metabolic Vascular Diseases, Chongqing Key Laboratory of Translational Medicine in Major Metabolic Diseases, The First Affiliated Hospital of Chongqing Medical University
Chongqing, Chongqing Municipality, China
Recruiting
Showing 1 of 1 sites. 1 of the 1 site on this study is recruiting right now — a site can stop enrolling while the study as a whole is still open.
Source: ClinicalTrials.gov record NCT05743933. Trialion does not run this study, is not paid to refer anyone to it, and cannot enrol you. Eligibility is always decided by the research team at the site.
Not the right study?
Answer three questions and see the studies recruiting near you, in plain language.
Find a study for me